At Alkermes, we develop innovative medicines that can change people’s lives for the better. We apply sophisticated science and technology designed to overcome common barriers to clinical success and help patients reach their treatment goals.
News
-
Alkermes Initiates Phase 2 Clinical Study of ALKS 33 for the Treatment of Alcohol Dependence
-
Alkermes Announces Positive Results from Phase 3 Clinical Study of Naltrexone for Extended-Release Injectable Suspension for the Treatment of Opioid Dependence
Events
Alkermes provides updates on the company’s business and pipeline progress at investor conferences throughout the year. If you are interested in listening to live or past events, or to check on upcoming events, please visit our investor relations section.
Careers
-
A career at Alkermes is all about making a difference - making a difference in the development of new medicines and most importantly, making a difference in the lives of our patients and caregivers. If you are interested in joining our dynamic team, please visit our careers section.
Learn More
Research Spotlight
-
Our approach to research and development is unparalleled.